Skip to main content
Caplight Logo









Aelius Biotech

Aelius Biotech

Private
Newcastle upon TyneHealthcare & Life Scienceshttps://www.aeliusbiotech.co.uk

Last Round

Early Funding

Apr 7, 2025

Total Funding Raised

$3.17M

Company Overview

Aelius Biotech is a biotechnology company that provides a laboratory gut model to simulate digestion for testing drugs and foodstuffs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

contract research organizationCROin-vitro gut modelgut-on-a-chipgastrointestinal modelingbioavailability testinganimal testing alternativemucus modelingorgan-on-a-chiphuman trialsdigestion modelingabsorption modelingpreclinical testingfunctional food testingnutraceutical testingoral formulation testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aelius Biotech Comparables

Compare Aelius Biotech with similar companies based on industry and business-model similarity.

Aelius Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
InnoGI Technologies
86%
Nium SA
84%
ProDigest
83%

Aelius Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingApr 7, 2025
GrantFeb 28, 2024
SeedNov 23, 2023

Key People

Founding team and executive leadership

Peter Chater

CEO

Executive Team

Aelius Biotech Investors

Notable investors and investment history

Aelius Biotech investors
InvestorRounds
Innovate UKGrant
Mercia VenturesEarly Funding, Seed
European Regional Development FundSeed
Mercia Asset ManagementEarly Funding, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 18, 2025

    Added Oxford Pharmascience, a startup in the pharmaceutical industry.

  • Sep 18, 2025

    Added Seaweed & Co, a startup in Food & Beverage / Health & Wellness.

Aelius Biotech Filings

Explore SEC and related filing metadata, where available.

Aelius Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Aelius Biotech's valuation, stock price, and market status.

Is Aelius Biotech a public or private company?

Aelius Biotech is a private company.

What is the current stock price of Aelius Biotech?

Aelius Biotech is a private company, so its shares have no public market price. Caplight tracks Aelius Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Aelius Biotech worth (valuation)?

Valuation information for Aelius Biotech is not publicly available.

Can I buy Aelius Biotech stock?

Aelius Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Aelius Biotech's last funding round?

Aelius Biotech's most recent funding round was Early Funding on April 7, 2025.

Who are the main investors in Aelius Biotech?

Key investors in Aelius Biotech include Mercia Asset Management.

Will Aelius Biotech IPO soon?

No public IPO plans have been announced for Aelius Biotech.

How can I track Aelius Biotech secondary market activity?

Caplight tracks bids, offers, and trades in Aelius Biotech's shares on secondary markets.

Firmographic Details

HeadquartersNewcastle upon Tyne
Employee Range16
Year Founded2018
Last FundingApr 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?